November 16, 2013 7:40pm
An earnings release is a ‘scorecard’ of sorts for a public regenerative medicine company.
The current LPS (loss per share) standings reflect the universes’ investing status; then add in their cash position for a better snapshot! By analyzing these comparisons, investors can begin to gauge the financial health versus the scientific opportunity of regenerative medicine research and whether or not it deserves their investment.
Members only. Please login.